Efficacy and vitreous levels of topical NSAIDs.

about

Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.

P2860

Q39208422-B0270951-8376-40C2-9C15-91C9B5B2EDF5

P2860

Efficacy and vitreous levels of topical NSAIDs.

Item

http://www.wikidata.org/entity/Q38546915

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy and vitreous levels of topical NSAIDs.

@en

type

Item

label

Efficacy and vitreous levels of topical NSAIDs.

@en

prefLabel

Efficacy and vitreous levels of topical NSAIDs.

@en

P1476

Efficacy and vitreous levels of topical NSAIDs

@en

P2093

Andrea Russo

http://www.w3.org/2001/XMLSchema#string

Ciro Costagliola

http://www.w3.org/2001/XMLSchema#string

Elena Gambicorti

http://www.w3.org/2001/XMLSchema#string

Francesco Morescalchi

http://www.w3.org/2001/XMLSchema#string

Sara Vezzoli

http://www.w3.org/2001/XMLSchema#string

Sarah Duse

http://www.w3.org/2001/XMLSchema#string

P2860

Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes

Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits

Origin and physiological roles of inflammation

Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis.

A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.

Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.

Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.

Etiology and treatment of macular edema.

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

P304

1767-1782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2015.1068756

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Semeraro

P577

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280103710

http://www.w3.org/2001/XMLSchema#string

P698

26173446

http://www.w3.org/2001/XMLSchema#string

Efficacy and vitreous levels of topical NSAIDs.

about

P2860

P2860

Efficacy and vitreous levels of topical NSAIDs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698